Genmab A/S

Ninety Eight Percent of Surveyed Rheumatologists Will Prescribe Roche's Actemra for Rheumatoid Arthritis.
Clinical Trials Week; 11/16/2009; 1095 words; ...Pfizer's Enbrel and Abbott's Humira, the two leading agents in...novel oral agents such as Pfizer's CP-690550 is significant as, on...expect to cover its competitors, Genmab/GlaxoSmithKline's Arzerra and Biogen Idec/Roche...

PanGenetics Announces Acquisition by Abbott of PG110 anti-NGF Antibody to Treat Chronic Pain.
Business Wire; 11/12/2009; 1713 words; ...chronic pain patients in the U.S. and EU and up to 30 percent...than 130 countries. Abbott's news releases and other information are available on the company's Web site at www.abbott.com...Cellzome, Funxional Therapeutics, Genmab, Micromet, Molecular Partners...

Switzerland : Lonza to produce cancer drug.
TendersInfo; 11/11/2009; 560 words; ...manufacturing center at Pease International Tradeport, on Tuesday announced it will manufacture GlaxoSmithKline and Genmab's antibody ArzerraTM, which was recently approved for use in patients with chronic lymphocytic leukemia by the United...

CS slashes Genmab rating to "underperform".
Nordic Business Report; 11/10/2009; 710 words; ...November 2009-CS slashes Genmab rating to "underperform...Danish biotech company Genmab A/S (CPH: GEN) to "underperform...estimate for the drug's sales in 2015 to USD435m from USD1bn. The stock in Genmab had plunged 10.92% to...

Bristol-Myers Squibb and Alder Biopharmaceuticals Enter Global Agreement on Rheumatoid Arthritis Biologic.
Business Wire; 11/10/2009; 1635 words; ...Bristol-Myers Squibb's extensive development and commercial...about one percent of the world's population,4 including more...inflammatory disease areas. Alder's management team combines decades...Plough, Seattle Genetics, Genmab, and two non-disclosed large...